Microalbuminuria and its relation to cardiovascular disease and risk factors. A population based study of 1254 hypertensive individuals

Journal of Human Hypertension

Volumn 11, Issue 11, 1997, Pages 727-732

  Jensen, J S ^a   Feldt Rasmussen, B ^a   Borch Johnsen, K ^a   Clausen, P ^a   Appleyard, M ^a   Jensen, G ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Acute myocardial infarction; Antihypertensive agents; Arterial hypertension; Atherosclerotic risk factors; Cardiovascular disease; Microalbuminuria; Urinary albumin excretion

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; ELECTROENCEPHALOGRAM; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MALE; MASS SCREENING; MICROALBUMINURIA; POPULATION RESEARCH; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; UNIVERSITY HOSPITAL;

EID: 0030831855     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000459     Document Type: Article

References (48)

1. Parving H-H, Mogensen CE, Jensen HÆ, Evrin P-E. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1974; i: 1190-1192.
2. Ljungman S, Microalbuminuria in essential hypertension. Am J Hypertens 1990; 3: 956-960.
3. Messent JWC et al. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study. Kidney Int 1992; 41: 836-839.
4. Torffvit O, Agardh C-D. The predictive value of albuminuria for cardiovascular and renal disease. A 5-year follow-up study of 476 patients with type 1 diabetes mellitus. J Diab Comp 1993; 7: 49-56.
5. Deckert T et al. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. Br Med J 1996; 312: 871-874.
6. Jarrett RJ et al. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diab Med 1984; 1: 17-19.
7. Schmitz A, Vaeth M. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diab Med 1988; 5: 1126-1134.
8. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Eight-to-nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 1992; 41: 731-735.
9. Mattock MB et al. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736-741.
10. Neil A et al. A prospective poulation-based study of microalbuminuria as a predictor of mortality in NIDDM. Diab Care 1993; 16: 996-1003.
11. Gall M-A et al. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995; 44: 1303-1309.
12. MacLeod JM, Lutale J, Marshall SM. Albumin excretion and vascular deaths in NIDDM. Diabetologia 1995; 38: 610-616.
13. Rossing P, Hougaard P, Borch-Johnsen K, Parving H-H. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. Br Med J 1996; 313: 779-784.
14. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988; ii: 530-533.
15. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297-300.
16. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation 1995; 91: 831-837.
17. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996; 14: 223-228.
18. The Copenhagen City Heart Study Group. The Copenhagen City Heart Study. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). Scand J Soc Med 1989; 170 (Suppl 41): 1-160.
19. Jensen G. Epidemiology of chest pain and angina pec-toris - with special reference to treatment needs. Acta Med Scand 1984; 214 (Suppl 682): 1-120.
20. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull Wld Hlth Org 1962; 27: 546-558.
21. Rose GA, Blackburn H. Cardiovascular survey methods. Geneva: WHO, WHO Monogr 1968: Ser No 56.
22. Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985; 45: 539-544.
23. Mogensen CE et al. Microalbuminuria: An early marker of renal involvement in diabetes. Uremia Invest 1986; 9(2): 85-95.
24. Marre M et al. Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin Chem 1987; 33: 209-213.
25. Watts GF, Morris RW, Khan K, Polak A. Urinary albumin excretion in healthy adult subjects: reference value and some factors affecting their interpretation. Clin Chim Acta 1988; 172: 191-198.
26. Gould MM et al. Associations of urinary albumin excretion rate with vascular disease in Europid non-diabetic subjects. J Diab Comp 1994; 8: 180-188.
27. Bigazzi R, Blanchi S, Campese V, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61: 94-97.
28. Agewall S et al. Microalbuminuria in treated hypertensive men at high risk of coronary disease. J Hypertens 1993; 11: 461-469.
29. Hoegsholm A et al. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension 1994; 24: 101-105.
30. Redon J et al. Ambulatory blood pressure and microalbuminuria in essential hypertension: Role of circardian variability. J Hypertens 1994; 12: 947-953.
31. Mimran A, Ribstein J, Du Cailar G, Halimi JM. Albuminuria in normals and essential hypertension. J Diab Compl 1994; 8: 150-156.
32. Pontremoli R et al. Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. Nephrol Dial Transplant 1995; 10 (Suppl 6): 6-9.
33. De Venuto G, Andreotti C, Matterei M, Pegoretti G. Long term captopril therapy at low doses reduces albumin excretion in patients with essential hypertension and no sign of renal impairment. J Hypertens 1985; 3: S143-S145.
34. Reams GP, Lau A, Hamory A, Bauer JH. Amlodipine therapy corrects renal abnormalities encountered in the hypertensive state. Am J Kidney Dis 1987; 10: 446-451.
35. Reams GP, Hamory A, Lau A, Bauer JH. Effect of nifedipine on renal function in patients with essential hypertension. Hypertension 1988; 11: 452-456.
36. Hartfort M et al. Cardiovascular and renal effects of long-term antihypertensive treatment. JAMA 1988; 259: 2553-2557.
37. Marre M et al. Microalbuminuria in uncomplicated essential hypertension and its reduction by antihypertensive treatment. Diabet Metab 1988; 14: 232-234.
38. Bianchi S, Bigazzi R, Baldari G, Campese VM. Microalbuminuria in patients with essential hypertension: effect of an angiotensin converting enzyme inhibitor and a calcium channel blocker. Am J Hypertens 1991; 4: 291-296
39. Bianchi S, Bigazzi R, Baldari G, Campese VM. Microalbuminuria in patients with essential hypertension: effect of several antihypertensive drugs. Am J Med 1992; 93: 525-528.
40. Karlberg B. Calcium antagonists in essential hypertension: effect on renal haemodynamics and microalbuminuria. J Int Med 1992; 231: 247-252.
41. Bigazzi R et al. Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension. Am J Hypertens 1993; 6: 108-113.
42. Erley CM et al. Microalbuminuria in essential hypertension, Reduction by different antihypertensive drugs. Hypertension 1993; 21: 810-815.
43. Feldt-Rasmussen B. Increased transcapillary escape rate of albumin in Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1986; 29: 282-286.
44. Nørgaard K, Jensen T, Feldt-Rasmussen B. Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 57-61.
45. Nannipieri M et al. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diab Care 1995; 18: 1-9.
46. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci 1995; 88: 629-633.
47. Stender S, Zilversmith DB. Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits. Arteriosclerosis 1981; 1: 38-49.
48. Nordestgaard BG, Stender S, Kjeldsen K. Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall. Arteriosclerosis 1988; 8: 421-428.